Outcome | Model 1 | Model 2 | Model 3 |
LVMI, g/m2.7 | 0.0626* | 0.0485 | 0.0433 |
LVMI2.7/EDV | 0.0008 | 0.0006 | 0.0005 |
RWT, ratio | 0.0000 | −0.0002 | 0.0000 |
LAVI, mL/m2 | −0.0066 | −0.0066 | −0.0035 |
EF, % | −0.0025 | −0.0005 | 0.0025 |
E/e′, ratio | 0.0144 | −0.0074 | −0.0341 |
GLS, % | 0.0041 | 0.0035 | 0.0014 |
GCS, % | −0.0377 | −0.0390 | −0.0413 |
SV, mL | 0.0073 | −0.0039 | 0.0001 |
RV peak S, cm/s | 0.0090 | 0.0075 | 0.0068 |
RV FAC | 0.0001 | 0.0001 | 0.0002 |
TRV max, cm/s | −0.0457 | −0.0459 | −0.0330 |
TAPSE, cm | −0.0010 | −0.0011 | −0.0010 |
M1: demographics (age and sex).
M2: M1+systolic blood pressure, antihypertensive med use.
M3: M2+other cardiovascular disease modifiable factors (diabetes mellitus, current smoking and high-density lipoprotein).
Values are per 10 min/day of sedentary behaviour.
*P value <0.01.
E, peak early diastolic transmitral inflow velocities; EDV, end diastolic volume; e′, average of mitral early diastolic septal and lateral annular velocities; EF, ejection fraction; GCS, global circumferential strain; GLS, global longitudinal strain; LAVI, left atrial volume index; LVMI, left ventricular mass index; M, model; RV, right ventricular; RV FAC, RV fractional area change; RWT, relative valve thickness; SV, stroke vol; TAPSE, tricuspid annular plane systolic excursion; TRV, tricuspid regurgitation velocity.